Characterization of the GHB Withdrawal Syndrome
The gamma-hydroxybutyric acid (GHB) withdrawal syndrome can have a fulminant course, complicated by severe complications such as delirium or seizures. Detoxification by tapering with pharmaceutical GHB is a safe way to manage GHB withdrawal. However, a detailed description of the course of the GHB w...
Main Authors: | Casper J. H. Wolf, Harmen Beurmanjer, Boukje A. G. Dijkstra, Alexander C. Geerlings, Marcia Spoelder, Judith R. Homberg, Arnt F. A. Schellekens |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2333 |
Similar Items
-
An Overview of the Putative Structural and Functional Properties of the GHBh1 Receptor through a Bioinformatics Approach
by: Casper J. H. Wolf, et al.
Published: (2023-03-01) -
Gamma-Hydroxybutyrate (GHB) Withdrawal
by: Everett, Worth W
Published: (2001-04-01) -
Gamma-hydroxybutyrate (GHB) and Gamma-butyrolactone (GBL): Analysis of overdose cases reported to the Swiss Toxicological Information Centre
by: Swiss Medical Weekly
Published: (2004-09-01) -
GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study
by: Peter Neu, et al.
Published: (2023-10-01) -
Gamma-hydroxybutyrate (GHB): A New Generation of Drugs from the Chemical Shelf
by: Peter X. Iten, et al.
Published: (2002-03-01)